CCL2 and atherosclerosis: In conclusion, from the in vitro test and in vivo test, we observed that MCP-1-motif MNPs could interact with monocytes and accumulate in the aorta of an atherosclerosis model, indicating a potential targeting tool for early-stage atherosclerosis.